Tailor-Made Cancer Drugs

pmineiro writes "A researcher at Washington University in St. Louis has developed a method for delivering an inactive drug complex into the body, which is only activated by certain messenger RNA sequences. This allows a drug to be selectively activated only in certain cellular contexts, e.g., cancer or HIV infection."